Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School
AstraZeneca
Medtronic
Johnson and Johnson
McKesson

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021670

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

NDA 021670 describes VISIONBLUE, which is a drug marketed by Dorc and is included in one NDA. It is available from one supplier. There are two patents protecting this drug. Additional details are available on the VISIONBLUE profile page.

The generic ingredient in VISIONBLUE is trypan blue. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trypan blue profile page.
Summary for 021670
Tradename:VISIONBLUE
Applicant:Dorc
Ingredient:trypan blue
Patents:2
Formulation / Manufacturing:see details
Pharmacology for NDA: 021670
Mechanism of ActionDyes
Medical Subject Heading (MeSH) Categories for 021670
Suppliers and Packaging for NDA: 021670
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670 NDA D.O.R.C. Dutch Ophthalmic Research Center (International) B.V. 68803-612 68803-612-10 10 POUCH in 1 CARTON (68803-612-10) > 1 SYRINGE, GLASS in 1 POUCH > .5 mL in 1 SYRINGE, GLASS

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION;OPHTHALMICStrength0.06%
Approval Date:Dec 16, 2004TE:RLD:Yes
Patent:  Start TrialPatent Expiration:Oct 26, 2019Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD OF APPLYING TRYPAN BLUE ONTO AN OUTER SURFACE OF THE ANTERIOR LENS CAPSULE TO FACILITATE REMOVAL OF THE LENS SUBSTANCE
Patent:  Start TrialPatent Expiration:May 7, 2019Product Flag?Substance Flag?Delist Request?
Patented Use:A METHOD OF APPLYING TRYPAN BLUE ONTO AN OUTER SURFACE OF THE ANTERIOR LENS CAPSULE TO FACILITATE REMOVAL OF THE LENS SUBSTANCE

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
McKesson
Boehringer Ingelheim
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.